Newsfeeds - Spark Newswire

1 minute read

Sangamo Therapeutics Q4 EPS $(0.32) Beats $(0.36) Estimate, Sales $27.23M Beat $26.86M Estimate

Today, 11:47 AM

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 23.08 percent decrease over losses of $(0.26) per share

SGMO

6 minute read

Sangamo Therapeutics Announces Evidence Of Clinical Benefit In Phase 1/2 STAAR Study In Fabry Disease

By Happy Mohamed

Today, 11:47 AM

- Sustained, elevated expression of alpha-galactosidase A (α-Gal A) activity observed in 13 patients for over two years for the longest treated patient as of cutoff

SGMO

13 minute read

Earnings

Earnings Scheduled For February 22, 2023

By Benzinga Insights

Today, 11:47 AM

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

ACVA

1 minute read

Earnings

Earnings Preview For Sangamo Therapeutics

By Benzinga Insights

Today, 11:47 AM

Sangamo Therapeutics (NASDAQ:SGMO) is set to give its latest quarterly earnings report on Wednesday, 2023-02-22. Here’s what investors…

SGMO

1 minute read

Wells Fargo Maintains Overweight on Sangamo Therapeutics, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 11:47 AM

Wells Fargo analyst Yanan Zhu maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Overweight and lowers the price target from $20 to $15.

SGMO

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 11:47 AM

On Wednesday, 258 companies hit new 52-week lows.

ACB

19 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 11:47 AM

Tuesday's session saw 325 companies set new 52-week lows.

AAPL

18 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 11:47 AM

Thursday's session saw 329 companies set new 52-week lows.

ABNB

1 minute read

Sangamo Therapeutics Q3 EPS $(0.34) Beats $(0.35) Estimate, Sales $26.46M Miss $26.59M Estimate

By Benzinga Newsdesk

Today, 11:47 AM

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.35) by 2.86 percent. This is a 3.03 percent decrease over losses of $(0.33) per share

SGMO